应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ATOS Atossa Genetics Inc
耶稣受难日休市 03-28 16:00:00 EDT
1.80
-0.03
-1.64%
盘后
1.83
+0.03
+1.67%
19:59 EDT
最高
1.91
最低
1.76
成交量
188.96万
今开
1.85
昨收
1.83
日振幅
8.47%
总市值
2.26亿
流通市值
2.12亿
总股本
1.25亿
成交额
346.26万
换手率
1.61%
流通股本
1.18亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Atossa Therapeutics, Inc.盘中异动 早盘股价大跌5.82%
自选股智能写手 · 03-26 21:49
Atossa Therapeutics, Inc.盘中异动 早盘股价大跌5.82%
Atossa Therapeutics, Inc.盘中异动 早盘急速上涨6.19%报1.77美元
自选股智能写手 · 03-25
Atossa Therapeutics, Inc.盘中异动 早盘急速上涨6.19%报1.77美元
Atossa Therapeutics, Inc.盘中异动 大幅下挫5.06%报1.60美元
自选股智能写手 · 03-22
Atossa Therapeutics, Inc.盘中异动 大幅下挫5.06%报1.60美元
Atossa Therapeutics, Inc.盘中异动 大幅上涨5.81%报1.64美元
自选股智能写手 · 03-20
Atossa Therapeutics, Inc.盘中异动 大幅上涨5.81%报1.64美元
Atossa Therapeutics, Inc.盘中异动 股价大涨5.81%报1.37美元
自选股智能写手 · 03-19
Atossa Therapeutics, Inc.盘中异动 股价大涨5.81%报1.37美元
Atossa Therapeutics Inc 预计每股亏损6美分 - 财报前瞻
Reuters · 03-18
Atossa Therapeutics Inc 预计每股亏损6美分 - 财报前瞻
Atossa Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元
自选股智能写手 · 03-16
Atossa Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元
Atossa Therapeutics, Inc.盘中异动 快速下跌5.95%报1.19美元
自选股智能写手 · 03-14
Atossa Therapeutics, Inc.盘中异动 快速下跌5.95%报1.19美元
Atossa Therapeutics, Inc.盘中异动 快速跳水5.34%
自选股智能写手 · 03-13
Atossa Therapeutics, Inc.盘中异动 快速跳水5.34%
Atossa Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元
自选股智能写手 · 03-12
Atossa Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元
Atossa Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%
自选股智能写手 · 03-11
Atossa Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%
Atossa Therapeutics, Inc.盘中异动 快速上涨5.18%
自选股智能写手 · 03-08
Atossa Therapeutics, Inc.盘中异动 快速上涨5.18%
Atossa Therapeutics, Inc.盘中异动 快速上涨5.22%报1.21美元
自选股智能写手 · 03-07
Atossa Therapeutics, Inc.盘中异动 快速上涨5.22%报1.21美元
Atossa Therapeutics Inc盘中异动 早盘股价大涨5.15%报1.020美元
自选股智能写手 · 02-14
Atossa Therapeutics Inc盘中异动 早盘股价大涨5.15%报1.020美元
Atossa Therapeutics Inc盘中异动 股价大涨5.80%
自选股智能写手 · 02-12
Atossa Therapeutics Inc盘中异动 股价大涨5.80%
Atossa Therapeutics Inc盘中异动 早盘股价大涨5.08%报0.865美元
自选股智能写手 · 01-18
Atossa Therapeutics Inc盘中异动 早盘股价大涨5.08%报0.865美元
Atossa Therapeutics Inc盘中异动 临近午盘股价大跌5.00%报0.865美元
自选股智能写手 · 01-17
Atossa Therapeutics Inc盘中异动 临近午盘股价大跌5.00%报0.865美元
加载更多
公司概况
公司名称:
Atossa Genetics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Atossa Therapeutics, Inc.于2009年4月30日在特拉华州注册成立。他们是一家临床阶段的生物制药公司,致力于在肿瘤学和传染病的重大未满足医疗需求领域发现和开发创新药物,目前专注于乳腺癌,其他乳房状况和COVID-19。他们正在开发的治疗乳腺癌和其他乳腺疾病的药物是Endoxifen,主要在两种情况下开发:一种是在乳腺癌诊断和手术之间的“机会窗口”中降低乳腺癌患者的肿瘤细胞活性;另一种适用于乳房组织致密的女性,以降低密度。他们正在开发的两种COVID-19药物是AT-H201,用于通过吸入改善中度至重度住院COVID-19患者的肺功能;和AT-301,一种供COVID-19患者在家使用的鼻腔喷雾剂。他们的业务战略是通过包括合作伙伴在内的临床研究来推进他们的项目,并通过收购、合作或内部开发机会性地在未满足的医疗需求领域增加项目。
发行价格:
--
{"stockData":{"symbol":"ATOS","market":"US","secType":"STK","nameCN":"Atossa Genetics Inc","latestPrice":1.8,"timestamp":1711656000000,"preClose":1.83,"halted":0,"volume":1889565,"hourTrading":{"tag":"盘后","latestPrice":1.83,"preClose":1.8,"latestTime":"19:59 EDT","volume":17709,"amount":31948.4221,"timestamp":1711670352670},"delay":0,"floatShares":117502745,"shares":125304064,"eps":-0.235978,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":-0.03,"latestTime":"03-28 16:00:00 EDT","open":1.85,"high":1.91,"low":1.755,"amount":3462629.7520649997,"amplitude":0.084699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.235978,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":1352350800000,"adjPreClose":1.83,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.85,"preClose":1.83,"latestTime":"09:14 EDT","volume":45017,"amount":82025.4711983,"timestamp":1711631648652},"postHourTrading":{"tag":"盘后","latestPrice":1.83,"preClose":1.8,"latestTime":"19:59 EDT","volume":17709,"amount":31948.4221,"timestamp":1711670352670},"volumeRatio":0.6753789541811797},"requestUrl":"/m/hq/s/ATOS?invite=TIGER025","defaultTab":"news","newsList":[{"id":"2422195736","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422195736","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422195736?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:49","pubTimestamp":1711460966,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时49分,Atossa Therapeutics, Inc.股票出现异动,股价大幅下跌5.82%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Stoke Therapeutics, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Praxis Precision Medicines, Inc.涨幅较大,Abvc Biopharma, Inc.、Stoke Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃,换手率分别为151.08%、21.63%、16.31%,振幅较大的相关个股有Stoke Therapeutics, Inc.、Bio-Path Holdings, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为29.69%、21.43%、18.81%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262149267a4f3505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262149267a4f3505&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422831541","title":"Atossa Therapeutics, Inc.盘中异动 早盘急速上涨6.19%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422831541","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422831541?lang=zh_cn&edition=full","pubTime":"2024-03-25 22:35","pubTimestamp":1711377314,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日22时35分,Atossa Therapeutics, Inc.股票出现波动,股价快速拉升6.19%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Xtl生物制药涨幅较大,Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为2497.14%、355.81%、63.90%,振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Brainstorm Cell Therapeutics Inc.,振幅分别为78.61%、52.02%、35.56%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325223515861e0e40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325223515861e0e40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421981768","title":"Atossa Therapeutics, Inc.盘中异动 大幅下挫5.06%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421981768","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421981768?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:19","pubTimestamp":1711117152,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日22时19分,Atossa Therapeutics, Inc.股票出现波动,股价大幅下跌5.06%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Outlook Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大,Outlook Therapeutics, Inc.、180 Life Sciences Corp.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为58.96%、18.85%、13.08%,振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts ,振幅分别为53.68%、43.92%、42.84%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222219127a4e8b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222219127a4e8b47&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420479537","title":"Atossa Therapeutics, Inc.盘中异动 大幅上涨5.81%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420479537","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420479537?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:31","pubTimestamp":1710941471,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时31分,Atossa Therapeutics, Inc.股票出现波动,股价大幅上涨5.81%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Jaguar Health, Inc.、Taysha Gene Therapies, Inc.、Design Therapeutics, Inc.涨幅较大,Jaguar Health, Inc.、Tc Biopharm Plc、Nls Pharmaceutics Ltd.较为活跃,换手率分别为34.18%、29.20%、14.72%,振幅较大的相关个股有Jaguar Health, Inc.、Salarius Pharmaceuticals, Inc.、Taysha Gene Therapies, Inc.,振幅分别为10.60%、8.99%、8.53%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202131117a4df8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202131117a4df8db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420959278","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.81%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420959278","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420959278?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:10","pubTimestamp":1710857433,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时10分,Atossa Therapeutics, Inc.股票出现波动,股价急速上涨5.81%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。其相关个股中,Fusion Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Enliven Therapeutics, Inc.涨幅较大,Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为733.00%、364.83%、133.09%,振幅较大的相关个股有Enveric Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Hoth Therapeutics, Inc.,振幅分别为44.55%、30.00%、27.83%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922103387e7a159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922103387e7a159&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420242128","title":"Atossa Therapeutics Inc 预计每股亏损6美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420242128","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420242128?lang=zh_cn&edition=full","pubTime":"2024-03-18 19:04","pubTimestamp":1710759851,"startTime":"0","endTime":"0","summary":" * Atossa Therapeutics Inc 预计在3月20日公布截至2023年12月31日的业绩时,季度收入将没有变化(预计)。* * LSEG的分析师平均预计Atossa Therapeutics Inc每股亏损6美分。* 华尔街对 Atossa Therapeutics Inc 的 12 个月目标价中位数为 4.00 美元,高于其上次收盘价 1.29 美元。3月18日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419907307","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419907307","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419907307?lang=zh_cn&edition=full","pubTime":"2024-03-16 00:33","pubTimestamp":1710520431,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日00时33分,Atossa Therapeutics, Inc.股票出现异动,股价大幅上涨5.00%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃,换手率分别为321.85%、79.11%、27.36%,振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物,振幅分别为114.29%、63.00%、49.00%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031600335187e7964f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031600335187e7964f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419764607","title":"Atossa Therapeutics, Inc.盘中异动 快速下跌5.95%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419764607","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419764607?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:53","pubTimestamp":1710424406,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时53分,Atossa Therapeutics, Inc.股票出现波动,股价急速下挫5.95%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。其相关个股中,知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大,知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为235.65%、135.78%、65.75%,振幅较大的相关个股有知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.,振幅分别为68.13%、40.32%、38.38%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142153267a4cb6c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142153267a4cb6c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419636519","title":"Atossa Therapeutics, Inc.盘中异动 快速跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419636519","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419636519?lang=zh_cn&edition=full","pubTime":"2024-03-13 23:00","pubTimestamp":1710342040,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日23时00分,Atossa Therapeutics, Inc.股票出现波动,股价大幅下跌5.34%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.14%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Agex Therapeutics, Inc.涨幅较大,Kintara Therapeutics, Inc.、Nucana Plc、Tc Biopharm Plc较为活跃,换手率分别为227.39%、79.06%、41.18%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Tc Biopharm Plc C/Wts 10/02/2028 、Nucana Plc,振幅分别为82.54%、66.67%、52.21%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313230040791a1e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313230040791a1e67&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418532456","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418532456","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418532456?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:33","pubTimestamp":1710250423,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时33分,Atossa Therapeutics, Inc.股票出现波动,股价急速上涨5.00%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Regulus Therapeutics Inc.、Tracon Pharmaceuticals, Inc.、Tc Biopharm Plc涨幅较大,Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm Plc较为活跃,换手率分别为176.76%、129.58%、34.97%,振幅较大的相关个股有Regulus Therapeutics Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Tc Biopharm Plc,振幅分别为47.38%、26.14%、13.45%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221334387e782ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221334387e782ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418036815","title":"Atossa Therapeutics, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418036815","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418036815?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:44","pubTimestamp":1710164690,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时44分,Atossa Therapeutics, Inc.股票出现异动,股价急速上涨5.05%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121445179195a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121445179195a0c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417605736","title":"Atossa Therapeutics, Inc.盘中异动 快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417605736","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417605736?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:34","pubTimestamp":1709908451,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时34分,Atossa Therapeutics, Inc.股票出现异动,股价快速拉升5.18%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Cero Therapeutics Holdings, Inc.涨幅较大,Psyence Biomedical Ltd.、Scisparc Ltd.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为232.02%、202.80%、176.37%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、In8Bio, Inc.,振幅分别为64.25%、49.61%、17.21%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240308223411861dca0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240308223411861dca0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417601027","title":"Atossa Therapeutics, Inc.盘中异动 快速上涨5.22%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417601027","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417601027?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:32","pubTimestamp":1709821949,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时32分,Atossa Therapeutics, Inc.股票出现波动,股价大幅拉升5.22%。Atossa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.41%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Immuron Limited涨幅较大,Aptevo Therapeutics Inc.、Immuron Limited、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为192.65%、123.61%、50.40%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Neximmune, Inc.,振幅分别为77.48%、26.23%、19.60%。Atossa Therapeutics, Inc.公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030722322979184681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030722322979184681&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411976585","title":"Atossa Therapeutics Inc盘中异动 早盘股价大涨5.15%报1.020美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411976585","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411976585?lang=zh_cn&edition=full","pubTime":"2024-02-14 23:50","pubTimestamp":1707925832,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日23时50分,Atossa Therapeutics Inc股票出现异动,股价快速上涨5.15%。Atossa Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc、Cogent Biosciences Inc涨幅较大,Kintara Therapeutics Inc、Azitra Inc、Transcode Therapeutics Inc较为活跃,换手率分别为53.40%、31.61%、30.30%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc、Renovaro Biosciences Inc,振幅分别为208.62%、51.31%、39.06%。Atossa Therapeutics Inc公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214235032861d53e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214235032861d53e0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410082830","title":"Atossa Therapeutics Inc盘中异动 股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410082830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410082830?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:40","pubTimestamp":1707748851,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日22时40分,Atossa Therapeutics Inc股票出现波动,股价急速上涨5.80%。Atossa Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.43%。Atossa Therapeutics Inc公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021222405187e6fc70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021222405187e6fc70&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404536435","title":"Atossa Therapeutics Inc盘中异动 早盘股价大涨5.08%报0.865美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404536435","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404536435?lang=zh_cn&edition=full","pubTime":"2024-01-18 22:36","pubTimestamp":1705588606,"startTime":"0","endTime":"0","summary":"北京时间2024年01月18日22时36分,Atossa Therapeutics Inc股票出现异动,股价急速拉升5.08%。Atossa Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.87%。其相关个股中,Celularity Inc、Biocardia Inc C/Wts 06/08/2024、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Kintara Therapeutics Inc、Transcode Therapeutics Inc、Zyversa Therapeutics Inc较为活跃,换手率分别为56.22%、40.84%、16.87%,振幅较大的相关个股有Celularity Inc、Acelyrin Inc、Transcode Therapeutics Inc,振幅分别为19.38%、17.61%、14.81%。Atossa Therapeutics Inc公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011822364687e664d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011822364687e664d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404890144","title":"Atossa Therapeutics Inc盘中异动 临近午盘股价大跌5.00%报0.865美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404890144","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404890144?lang=zh_cn&edition=full","pubTime":"2024-01-17 01:00","pubTimestamp":1705424457,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日01时00分,Atossa Therapeutics Inc股票出现异动,股价急速跳水5.00%。截至发稿,该股报0.865美元/股,成交量13.3254万股,换手率0.11%,振幅3.30%。Atossa Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.14%。Atossa Therapeutics Inc公司简介:Atossa Therapeutics Inc 是一家临床阶段的生物制药公司,在肿瘤学中未满足的重大医疗需求领域开发专利创新药物。该公司正在开发的治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240117010057790969b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240117010057790969b4&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atossatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0714},{"period":"1month","weight":0.7476},{"period":"3month","weight":1.0455},{"period":"6month","weight":1.444},{"period":"1year","weight":1.6049},{"period":"ytd","weight":1.0455}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atossa Therapeutics, Inc.于2009年4月30日在特拉华州注册成立。他们是一家临床阶段的生物制药公司,致力于在肿瘤学和传染病的重大未满足医疗需求领域发现和开发创新药物,目前专注于乳腺癌,其他乳房状况和COVID-19。他们正在开发的治疗乳腺癌和其他乳腺疾病的药物是Endoxifen,主要在两种情况下开发:一种是在乳腺癌诊断和手术之间的“机会窗口”中降低乳腺癌患者的肿瘤细胞活性;另一种适用于乳房组织致密的女性,以降低密度。他们正在开发的两种COVID-19药物是AT-H201,用于通过吸入改善中度至重度住院COVID-19患者的肺功能;和AT-301,一种供COVID-19患者在家使用的鼻腔喷雾剂。他们的业务战略是通过包括合作伙伴在内的临床研究来推进他们的项目,并通过收购、合作或内部开发机会性地在未满足的医疗需求领域增加项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.32737},{"month":2,"riseRate":0.583333,"avgChangeRate":0.115141},{"month":3,"riseRate":0.416667,"avgChangeRate":0.101791},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.066734},{"month":5,"riseRate":0.454545,"avgChangeRate":0.007784},{"month":6,"riseRate":0.636364,"avgChangeRate":0.153804},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.141756},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.062727},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.049565},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.211226},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.047831},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.103392}],"exchange":"NASDAQ","name":"Atossa Genetics Inc","nameEN":"Atossa Genetics"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atossa Genetics Inc(ATOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atossa Genetics Inc,ATOS,Atossa Genetics Inc股票,Atossa Genetics Inc股票老虎,Atossa Genetics Inc股票老虎国际,Atossa Genetics Inc行情,Atossa Genetics Inc股票行情,Atossa Genetics Inc股价,Atossa Genetics Inc股市,Atossa Genetics Inc股票价格,Atossa Genetics Inc股票交易,Atossa Genetics Inc股票购买,Atossa Genetics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atossa Genetics Inc(ATOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}